Advanced Search
RONG Dongjing, BAI Qing, ZHANG Yu'an, YANG Yuqiong. Application of urinary protein and umbilical artery blood flow monitoring in gestational hypertension[J]. Journal of Xuzhou Medical University, 2020, 40(1): 38-41. DOI: 10.3969/j.issn.2096-3882.2020.01.09
Citation: RONG Dongjing, BAI Qing, ZHANG Yu'an, YANG Yuqiong. Application of urinary protein and umbilical artery blood flow monitoring in gestational hypertension[J]. Journal of Xuzhou Medical University, 2020, 40(1): 38-41. DOI: 10.3969/j.issn.2096-3882.2020.01.09

Application of urinary protein and umbilical artery blood flow monitoring in gestational hypertension

More Information
  • Received Date: August 26, 2018
  • Revised Date: May 20, 2019
  • Objective To evaluate the application of urinary microalbumin/creatinine, 24 h proteinuria and umbilical artery blood flow monitoring in gestational hypertension. Methods Totally 193 patients with gestational hypertension who were admitted into Department of Nephropathy, the Third People's Hospital of Yunnan Province from March 2014 to December 2017 were selected. They were divided into three groups according to their conditions: a gestational hypertension group (Group I, n=65), a mild preeclampsia group (GroupⅡ, n=62) and a severe preeclampsia group (Group Ⅲ, n=66). Meanwhile, another 60 healthy pregnant women were selected as a control group. Then, urinary samples were collected. The urinary microalbumin and creatinine levels were detected by ELISA, and their ratio was calculated. The amount of 24 h proteinuria was detected by the pyrogallol red molybdate complex method. The peak systolic velocity/end diastolic velocity (S/D) and resistance index (RI) of umbilical artery were detected with doppler ultrasound. Furthermore, gestational outcomes were recorded to analyze the value of each indicator to predict adverse gestational outcomes. Results The ratio of urinary microalbumin/creatinine, 24 h proteinuria and umbilical artery S/D and RI were all increased in the control group, and GroupsⅠ, Ⅱ and Ⅲ, with statistical differences between each groups (P<0.05). Group Ⅱ presented higher incidences of fetal intrauterine distress, premature delivery and total adverse pregnant outcome than GroupⅠand the control group, while higher incidences were found in placental abruption, postpartum hemorrhage, fetal intrauterine distress, hypoxic-ischemic encephalopathy, premature delivery and total adverse pregnancy outcome in Group Ⅲ, compared with those in GroupⅠ and the control group (P<0.05). According to the ROC curve, the ratio of urinary microalbumin/creatinine, 24 h proteinuria and umbilical artery S/D and RI can well predict adverse pregnant outcome, with AUC of 0.823, 0.734, 0.813 and 0.776. Conclusions The ratio of urinary microalbumin/creatinine, 24 h proteinuria and umbilical artery S/D and RI can predict adverse pregnant outcome.
  • [1]
    侯林华. 妊娠期动态血压监测对预测妊娠期高血压疾病结局的意义 [J]. 临床合理用药杂志, 2018, 11(4):53-54, 57. DOI: 10.15887/j.cnki.13-1389/r.2018.04.026.
    [2]
    王丽, 王远流. CysC、HCY及mALB联合检测在妊娠期高血压疾病肾功能损伤患者早期诊断中的应用 [J]. 中国妇幼健康研究, 2017, 28(12): 1675-1677. DOI: 10.3969/j.issn.1673-5293.2017.12.055.
    [3]
    Kazemian E, Sotoudeh G, Dorosty-Motlagh AR, et al. Maternal obesity and energy intake as risk factors of pregnancy-induced hypertension among Iranian women [J]. J Health Popul Nutr, 2014, 32(3):486-493.
    [4]
    桂元, 詹继东, 徐芳, 等. 血清胱抑素C和尿微量白蛋白早期诊断妊娠期高血压疾病的价值[J]. 中国妇幼保健, 2017, 32(4): 709-711. DOI: 10.7620/zgfybj.j.issn.1001-4411.2017.04.25.
    [5]
    刘强, 张登洪, 杨小梅, 等. 尿微量白蛋白/肌酐比值及β2-微球蛋白联合检测对妊娠期高血压疾病早期肾损伤的临床价值 [J]. 四川医学, 2017, 38(1): 69-71. DOI: 10.16252 /j.cnki.issn1004-0501-2017.01.022.
    [6]
    Yan Q, Wang H, Liu R, et al. Influence of random urine albumin-creatinine ratio of pregnant women with hypertension during the gestation period on perinatal outcome [J]. Exp Ther Med, 2016, 12(4):2521-2526.
    [7]
    Ayansina D, Black C, Hall SJ, et al. Long term effects of gestational hypertension and pre-eclampsia on kidney function: record linkage study [J]. Pregnancy Hypertens, 2016, 6(4): 344-349. DOI: 10.1016/j.preghy.2016.08.231.
    [8]
    姜艳艳, 张秀果. 妊娠期高血压疾病尿微量白蛋白/肌酐比值与24h尿蛋白定量的相关性[J]. 热带医学杂志, 2014, 14(12): 1597-1598, 1616.
    [9]
    Cabiddu G, Castellino S, Gernone G, et al. A best practice position statement on pregnancy in chronic kidney disease: the Italian Study Group on Kidney and Pregnancy [J]. J Nephrol, 2016, 29(3):277-303. DOI: 10.1007/s40620-016-0285-6.
    [10]
    周俏苗, 郑海玲. 尿微量白蛋白与妊娠期高血压疾病早期肾损伤的关系研究 [J]. 海南医学, 2014, 25(21): 3188-3190. DOI: 10.3969/j.issn.1003-6350.2014.21.1250.
    [11]
    Gupta S,Chauhan M, Sen J, et al. Effect of transdermal nitroglycerine on doppler velocity waveforms of the uterine, umbilical and fetal middle cerebral arteries in patients with chronic placental insufficiency: a prospective RCT [J]. J Clin Diagn Res, 2017, 11(7): QC13-QC17. DOI: 10.7860/JCDR/2017/21438.10282.
    [12]
    徐晔. 脐血流监测对妊娠期高血压疾病孕妇妊娠结局的意义探讨 [J]. 实用临床医药杂志, 2012, 16(11): 138-140.
    [13]
    马斌, 王艺璇, 李天刚, 等. 三维能量多普勒超声在妊娠期高血压疾病胎盘血流灌注监测中的价值 [J]. 中国妇幼保健, 2018, 33(4): 918-921. DOI: 10.7620/zgfybj.j.issn.1001-4411.2018.04.63.
    [14]
    赵晟, 姜凡, 李亮, 等. 超声多普勒多参数评价妊娠期高血压疾病患者胎儿宫内情况 [J]. 安徽医科大学学报, 2017, 52(8): 1183-1188. DOI: 10.19405/j.cnki.issn1000-1492.2017.08. 018.
    [15]
    王莹, 黄海鸣, 鲁晓燕, 等. 妊娠期高血压疾病(HDP)患者子宫动脉及胎儿脐动脉血流动力学变化与结局的探讨 [J]. 中外医疗, 2017, 36(27): 39-40, 43. DOI: 10.16662/j.cnki.1674-0742.2017.27.039.

Catalog

    Article views (1596) PDF downloads (925) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return